Tamim Shaikh
Concepts (364)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Abnormalities, Multiple | 14 | 2015 | 178 | 2.390 |
Why?
| Chromosome Deletion | 16 | 2021 | 104 | 2.380 |
Why?
| DNA Copy Number Variations | 9 | 2023 | 172 | 1.740 |
Why?
| Chromosomes, Human, Pair 22 | 15 | 2019 | 41 | 1.490 |
Why?
| Repetitive Sequences, Nucleic Acid | 12 | 2019 | 113 | 1.240 |
Why?
| Craniofacial Abnormalities | 7 | 2021 | 62 | 1.190 |
Why?
| Oligonucleotide Array Sequence Analysis | 18 | 2011 | 772 | 1.160 |
Why?
| Gene Dosage | 12 | 2011 | 143 | 1.140 |
Why?
| Gene Duplication | 7 | 2011 | 67 | 1.090 |
Why?
| Vitamin B 12 | 3 | 2017 | 120 | 1.060 |
Why?
| Host Cell Factor C1 | 3 | 2017 | 14 | 1.050 |
Why?
| Heart Defects, Congenital | 4 | 2021 | 752 | 1.050 |
Why?
| Segmental Duplications, Genomic | 3 | 2023 | 7 | 1.040 |
Why?
| Chromosome Disorders | 3 | 2021 | 39 | 1.030 |
Why?
| Intellectual Disability | 5 | 2021 | 153 | 0.990 |
Why?
| Williams Syndrome | 2 | 2021 | 13 | 0.830 |
Why?
| Translocation, Genetic | 12 | 2011 | 97 | 0.820 |
Why?
| Chromosome Breakage | 10 | 2010 | 21 | 0.760 |
Why?
| Genomic Structural Variation | 1 | 2021 | 12 | 0.730 |
Why?
| Chromosome Mapping | 12 | 2023 | 503 | 0.720 |
Why?
| Polymorphism, Single Nucleotide | 18 | 2015 | 2070 | 0.700 |
Why?
| Zebrafish | 4 | 2020 | 448 | 0.680 |
Why?
| In Situ Hybridization, Fluorescence | 21 | 2019 | 319 | 0.660 |
Why?
| Developmental Disabilities | 7 | 2021 | 254 | 0.660 |
Why?
| Gene Deletion | 6 | 2011 | 374 | 0.650 |
Why?
| Repressor Proteins | 3 | 2017 | 400 | 0.620 |
Why?
| Chromosome Aberrations | 7 | 2018 | 148 | 0.600 |
Why?
| Mutation | 12 | 2021 | 3671 | 0.600 |
Why?
| Genetic Variation | 9 | 2016 | 935 | 0.570 |
Why?
| Vestibular Diseases | 2 | 2015 | 25 | 0.570 |
Why?
| Seizures | 1 | 2021 | 395 | 0.570 |
Why?
| Genetic Diseases, X-Linked | 2 | 2017 | 25 | 0.570 |
Why?
| Hematologic Diseases | 2 | 2015 | 61 | 0.560 |
Why?
| Chromosomes, Human, Pair 16 | 5 | 2021 | 31 | 0.500 |
Why?
| Chromosomes, Human, Pair 1 | 4 | 2010 | 72 | 0.500 |
Why?
| Histone Demethylases | 1 | 2015 | 31 | 0.480 |
Why?
| Genome, Human | 6 | 2021 | 393 | 0.480 |
Why?
| Amino Acyl-tRNA Synthetases | 1 | 2015 | 30 | 0.480 |
Why?
| Chromosomes, Human, Pair 11 | 6 | 2003 | 57 | 0.470 |
Why?
| Neoplasm Proteins | 2 | 2015 | 428 | 0.460 |
Why?
| Face | 2 | 2015 | 168 | 0.450 |
Why?
| Molecular Sequence Data | 22 | 2015 | 2842 | 0.450 |
Why?
| Blepharophimosis | 1 | 2014 | 3 | 0.450 |
Why?
| Skin Abnormalities | 1 | 2014 | 10 | 0.450 |
Why?
| Frameshift Mutation | 1 | 2014 | 32 | 0.450 |
Why?
| DNA-Binding Proteins | 5 | 2015 | 1423 | 0.450 |
Why?
| Chromosomes, Human, Pair 6 | 2 | 2013 | 52 | 0.440 |
Why?
| Brain Diseases | 1 | 2015 | 132 | 0.440 |
Why?
| Codon, Nonsense | 1 | 2014 | 40 | 0.440 |
Why?
| Genes, X-Linked | 1 | 2013 | 18 | 0.440 |
Why?
| Hyperhomocysteinemia | 1 | 2013 | 26 | 0.430 |
Why?
| Amino Acid Metabolism, Inborn Errors | 1 | 2013 | 21 | 0.430 |
Why?
| Syndrome | 10 | 2023 | 342 | 0.420 |
Why?
| Base Sequence | 19 | 2017 | 2157 | 0.420 |
Why?
| Histone Acetyltransferases | 1 | 2014 | 63 | 0.420 |
Why?
| Zebrafish Proteins | 1 | 2014 | 258 | 0.380 |
Why?
| Autism Spectrum Disorder | 1 | 2016 | 375 | 0.370 |
Why?
| Chromosomes, Human, Pair 13 | 2 | 2009 | 16 | 0.370 |
Why?
| Sequence Deletion | 5 | 2011 | 180 | 0.360 |
Why?
| Chromosomes, Human, Pair 10 | 2 | 2011 | 18 | 0.360 |
Why?
| Epilepsy | 1 | 2015 | 314 | 0.360 |
Why?
| Gene Expression Regulation, Developmental | 2 | 2014 | 816 | 0.360 |
Why?
| Chromosomes, Human, Pair 21 | 2 | 2011 | 39 | 0.350 |
Why?
| Nuclear Proteins | 1 | 2015 | 644 | 0.350 |
Why?
| Carrier Proteins | 1 | 2014 | 728 | 0.350 |
Why?
| Genomics | 2 | 2023 | 715 | 0.350 |
Why?
| Down Syndrome | 1 | 2016 | 454 | 0.340 |
Why?
| Humans | 74 | 2023 | 128896 | 0.340 |
Why?
| Phenotype | 14 | 2021 | 3059 | 0.340 |
Why?
| Infant | 19 | 2018 | 8994 | 0.320 |
Why?
| Databases, Genetic | 2 | 2010 | 226 | 0.310 |
Why?
| Chromosomes, Human, Pair 3 | 1 | 2008 | 47 | 0.310 |
Why?
| DNA Mutational Analysis | 7 | 2015 | 391 | 0.310 |
Why?
| Congenital Abnormalities | 1 | 2008 | 74 | 0.300 |
Why?
| Child | 21 | 2021 | 20824 | 0.290 |
Why?
| Autistic Disorder | 1 | 2010 | 184 | 0.280 |
Why?
| Genome-Wide Association Study | 7 | 2021 | 1334 | 0.270 |
Why?
| Genetic Predisposition to Disease | 7 | 2013 | 2270 | 0.260 |
Why?
| Child, Preschool | 18 | 2021 | 10457 | 0.260 |
Why?
| Nondisjunction, Genetic | 2 | 2010 | 3 | 0.260 |
Why?
| Branchial Region | 2 | 2017 | 35 | 0.260 |
Why?
| Meiosis | 2 | 2010 | 63 | 0.250 |
Why?
| Gene Knockdown Techniques | 3 | 2020 | 315 | 0.250 |
Why?
| Hyperglycinemia, Nonketotic | 2 | 2017 | 48 | 0.240 |
Why?
| DiGeorge Syndrome | 4 | 2015 | 30 | 0.230 |
Why?
| Amino Acid Sequence | 4 | 2020 | 2047 | 0.230 |
Why?
| Primates | 5 | 2019 | 120 | 0.230 |
Why?
| Rhabdoid Tumor | 4 | 2009 | 85 | 0.220 |
Why?
| Polymerase Chain Reaction | 8 | 2011 | 1045 | 0.220 |
Why?
| Gene Amplification | 4 | 2001 | 102 | 0.210 |
Why?
| Sequence Alignment | 6 | 2015 | 333 | 0.210 |
Why?
| Models, Genetic | 5 | 2011 | 586 | 0.190 |
Why?
| Genetic Association Studies | 3 | 2020 | 356 | 0.190 |
Why?
| Genetic Diseases, Inborn | 1 | 2001 | 38 | 0.190 |
Why?
| Tanzania | 1 | 2021 | 42 | 0.180 |
Why?
| Chromosome Breakpoints | 1 | 2021 | 6 | 0.180 |
Why?
| Chromosomes, Human, Pair 15 | 1 | 2021 | 55 | 0.180 |
Why?
| Transcription, Genetic | 2 | 2017 | 1408 | 0.180 |
Why?
| Male | 25 | 2021 | 63146 | 0.180 |
Why?
| Forkhead Transcription Factors | 2 | 2014 | 182 | 0.180 |
Why?
| DNA, Complementary | 2 | 1999 | 270 | 0.180 |
Why?
| Animals | 16 | 2020 | 34628 | 0.170 |
Why?
| 22q11 Deletion Syndrome | 1 | 2019 | 2 | 0.170 |
Why?
| Spasms, Infantile | 1 | 2021 | 118 | 0.170 |
Why?
| Receptors, GABA-A | 1 | 2020 | 93 | 0.160 |
Why?
| Genotype | 8 | 2015 | 1834 | 0.160 |
Why?
| Karyotyping | 5 | 2018 | 107 | 0.160 |
Why?
| Protein Subunits | 1 | 2020 | 230 | 0.160 |
Why?
| Nucleic Acid Hybridization | 3 | 2007 | 191 | 0.160 |
Why?
| Prader-Willi Syndrome | 2 | 2013 | 27 | 0.150 |
Why?
| Holoprosencephaly | 1 | 2018 | 8 | 0.150 |
Why?
| Cell Differentiation | 2 | 2017 | 1854 | 0.150 |
Why?
| Cell Cycle Proteins | 2 | 1999 | 576 | 0.150 |
Why?
| Sequence Homology, Nucleic Acid | 6 | 2008 | 150 | 0.150 |
Why?
| Chromosomal Proteins, Non-Histone | 2 | 2009 | 111 | 0.140 |
Why?
| RNA Polymerase III | 1 | 1997 | 26 | 0.140 |
Why?
| AT Rich Sequence | 3 | 2010 | 4 | 0.140 |
Why?
| Methylmalonic Acid | 1 | 2017 | 62 | 0.140 |
Why?
| Primary Cell Culture | 1 | 2017 | 159 | 0.140 |
Why?
| Gene Expression Regulation | 3 | 2017 | 2520 | 0.130 |
Why?
| Sequence Analysis, DNA | 5 | 2011 | 778 | 0.130 |
Why?
| Vitamin B 12 Deficiency | 1 | 2017 | 77 | 0.130 |
Why?
| Cohort Studies | 2 | 2021 | 5394 | 0.130 |
Why?
| Polymorphism, Genetic | 4 | 2005 | 641 | 0.130 |
Why?
| Glycine | 1 | 2017 | 162 | 0.130 |
Why?
| Glucose Transporter Type 3 | 1 | 2015 | 13 | 0.120 |
Why?
| Aminoacylation | 1 | 2015 | 12 | 0.120 |
Why?
| Motor Activity | 1 | 2020 | 666 | 0.120 |
Why?
| DNA Probes | 2 | 2008 | 61 | 0.120 |
Why?
| Chromosomal Instability | 2 | 2019 | 18 | 0.120 |
Why?
| Female | 21 | 2021 | 68162 | 0.120 |
Why?
| Heterozygote | 5 | 2020 | 268 | 0.120 |
Why?
| Gene Expression | 1 | 2020 | 1476 | 0.120 |
Why?
| Forkhead Box Protein L2 | 1 | 2014 | 2 | 0.110 |
Why?
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2013 | 245 | 0.110 |
Why?
| Oxidoreductases | 1 | 2014 | 91 | 0.110 |
Why?
| RNA, Transfer | 1 | 2015 | 131 | 0.110 |
Why?
| Sulfurtransferases | 1 | 2013 | 9 | 0.110 |
Why?
| Glutaredoxins | 1 | 2013 | 12 | 0.110 |
Why?
| Exome | 1 | 2015 | 219 | 0.110 |
Why?
| Body Patterning | 1 | 2014 | 128 | 0.110 |
Why?
| Inverted Repeat Sequences | 2 | 2010 | 19 | 0.110 |
Why?
| Neural Crest | 1 | 2014 | 120 | 0.110 |
Why?
| Urogenital Abnormalities | 1 | 2014 | 52 | 0.110 |
Why?
| Hypothyroidism | 1 | 2013 | 71 | 0.100 |
Why?
| Infant, Newborn | 4 | 2017 | 5704 | 0.100 |
Why?
| Comparative Genomic Hybridization | 4 | 2018 | 32 | 0.100 |
Why?
| Green Fluorescent Proteins | 1 | 2014 | 392 | 0.100 |
Why?
| Elastin | 1 | 2013 | 78 | 0.100 |
Why?
| Mosaicism | 2 | 2010 | 71 | 0.100 |
Why?
| Microarray Analysis | 2 | 2010 | 122 | 0.100 |
Why?
| Chondrocytes | 1 | 2014 | 203 | 0.100 |
Why?
| Mental Disorders | 1 | 2021 | 1024 | 0.100 |
Why?
| Proteins | 2 | 2013 | 945 | 0.100 |
Why?
| Fibroblasts | 1 | 2017 | 946 | 0.100 |
Why?
| Nucleic Acid Amplification Techniques | 2 | 2009 | 35 | 0.100 |
Why?
| Vesicular Acetylcholine Transport Proteins | 1 | 2011 | 3 | 0.100 |
Why?
| Philadelphia | 1 | 2011 | 44 | 0.100 |
Why?
| Age of Onset | 1 | 2013 | 494 | 0.100 |
Why?
| Nerve Growth Factors | 1 | 2011 | 73 | 0.090 |
Why?
| Alleles | 4 | 2020 | 847 | 0.090 |
Why?
| RNA, Small Interfering | 1 | 2013 | 575 | 0.090 |
Why?
| HEK293 Cells | 1 | 2013 | 673 | 0.090 |
Why?
| Alu Elements | 2 | 2000 | 27 | 0.090 |
Why?
| Child Development Disorders, Pervasive | 1 | 2011 | 61 | 0.090 |
Why?
| Chromosomes, Human, Pair 8 | 1 | 2010 | 36 | 0.090 |
Why?
| Cloning, Molecular | 3 | 2005 | 536 | 0.090 |
Why?
| Binding Sites | 1 | 2013 | 1238 | 0.090 |
Why?
| Stem Cells | 1 | 2014 | 572 | 0.090 |
Why?
| Transcription Factors | 2 | 2009 | 1634 | 0.080 |
Why?
| Cell Movement | 1 | 2014 | 932 | 0.080 |
Why?
| Base Pairing | 1 | 2009 | 62 | 0.080 |
Why?
| Chromosomes, Human, Pair 20 | 1 | 2009 | 16 | 0.080 |
Why?
| Mice, Transgenic | 1 | 2014 | 2073 | 0.080 |
Why?
| Blindness, Cortical | 1 | 2008 | 5 | 0.080 |
Why?
| Hematologic Neoplasms | 1 | 2011 | 141 | 0.080 |
Why?
| Chromosomes, Human, Pair 7 | 1 | 2008 | 15 | 0.080 |
Why?
| DNA, Circular | 1 | 2008 | 15 | 0.080 |
Why?
| Synaptic Transmission | 1 | 2011 | 258 | 0.080 |
Why?
| Evolution, Molecular | 2 | 2019 | 465 | 0.080 |
Why?
| DNA Primers | 5 | 2003 | 522 | 0.080 |
Why?
| Gene Silencing | 1 | 2009 | 180 | 0.080 |
Why?
| Cleft Lip | 1 | 2008 | 42 | 0.080 |
Why?
| RNA, Messenger | 2 | 2013 | 2700 | 0.080 |
Why?
| Molecular Probe Techniques | 1 | 2008 | 9 | 0.070 |
Why?
| Haploinsufficiency | 3 | 2013 | 47 | 0.070 |
Why?
| Brain | 3 | 2017 | 2592 | 0.070 |
Why?
| Neuroblastoma | 1 | 2009 | 152 | 0.070 |
Why?
| Beckwith-Wiedemann Syndrome | 1 | 2007 | 7 | 0.070 |
Why?
| Astrocytoma | 1 | 2008 | 120 | 0.070 |
Why?
| Hernia, Diaphragmatic | 1 | 2007 | 69 | 0.070 |
Why?
| Synapses | 1 | 2011 | 379 | 0.070 |
Why?
| Protein Binding | 1 | 2013 | 2086 | 0.070 |
Why?
| DNA | 4 | 2010 | 1406 | 0.070 |
Why?
| Central Nervous System | 1 | 2009 | 254 | 0.070 |
Why?
| Nerve Tissue Proteins | 1 | 2011 | 568 | 0.070 |
Why?
| Young Adult | 3 | 2018 | 12286 | 0.070 |
Why?
| Cleft Palate | 1 | 2007 | 63 | 0.070 |
Why?
| Oncogene Proteins, Fusion | 1 | 2008 | 195 | 0.070 |
Why?
| Gene Frequency | 4 | 2013 | 503 | 0.070 |
Why?
| Learning | 1 | 2010 | 381 | 0.070 |
Why?
| Proto-Oncogene Proteins B-raf | 1 | 2008 | 210 | 0.070 |
Why?
| Teratoma | 1 | 2007 | 101 | 0.070 |
Why?
| Pulmonary Alveoli | 1 | 2009 | 403 | 0.070 |
Why?
| Research Design | 2 | 2009 | 1038 | 0.060 |
Why?
| Genes, Neurofibromatosis 1 | 1 | 2005 | 4 | 0.060 |
Why?
| Chromosomes, Human, Pair 18 | 1 | 2005 | 9 | 0.060 |
Why?
| Computational Biology | 1 | 2010 | 587 | 0.060 |
Why?
| Attention Deficit Disorder with Hyperactivity | 1 | 2009 | 379 | 0.060 |
Why?
| Adult | 8 | 2015 | 35361 | 0.060 |
Why?
| Nucleic Acid Conformation | 1 | 2008 | 705 | 0.060 |
Why?
| Schizophrenia | 1 | 2009 | 433 | 0.060 |
Why?
| Conserved Sequence | 1 | 2005 | 228 | 0.060 |
Why?
| Trisomy | 1 | 2005 | 75 | 0.060 |
Why?
| Gene Expression Profiling | 1 | 2011 | 1694 | 0.060 |
Why?
| Biological Evolution | 4 | 1996 | 426 | 0.060 |
Why?
| Chromosome Fragile Sites | 1 | 2003 | 1 | 0.060 |
Why?
| Bronchopulmonary Dysplasia | 1 | 2009 | 383 | 0.060 |
Why?
| Mice, Knockout | 1 | 2010 | 2770 | 0.060 |
Why?
| Chromosomes, Human, 21-22 and Y | 1 | 2003 | 4 | 0.060 |
Why?
| Chromosomes, Human, Pair 4 | 1 | 2003 | 29 | 0.050 |
Why?
| Genetic Testing | 2 | 2011 | 424 | 0.050 |
Why?
| Dinucleotide Repeats | 1 | 2003 | 4 | 0.050 |
Why?
| Chromosomes, Human, Pair 17 | 1 | 2003 | 55 | 0.050 |
Why?
| Adolescent | 8 | 2018 | 20197 | 0.050 |
Why?
| Cell Line | 4 | 2019 | 2759 | 0.050 |
Why?
| DNA Transposable Elements | 2 | 1995 | 118 | 0.050 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2008 | 957 | 0.050 |
Why?
| Mice | 4 | 2011 | 16543 | 0.050 |
Why?
| Consensus Sequence | 3 | 1997 | 72 | 0.050 |
Why?
| Hereditary Sensory and Motor Neuropathy | 1 | 2001 | 1 | 0.050 |
Why?
| Angelman Syndrome | 1 | 2001 | 11 | 0.050 |
Why?
| Chromosomes, Human | 1 | 2001 | 41 | 0.050 |
Why?
| Genetic Markers | 2 | 1999 | 335 | 0.050 |
Why?
| Charcot-Marie-Tooth Disease | 1 | 2001 | 22 | 0.050 |
Why?
| Haplotypes | 1 | 2023 | 473 | 0.050 |
Why?
| Adrenocorticotropic Hormone | 1 | 2021 | 131 | 0.050 |
Why?
| Recombination, Genetic | 1 | 2001 | 186 | 0.040 |
Why?
| Disease Models, Animal | 1 | 2010 | 3994 | 0.040 |
Why?
| Pan paniscus | 1 | 2000 | 4 | 0.040 |
Why?
| Contig Mapping | 1 | 2000 | 10 | 0.040 |
Why?
| Artifacts | 1 | 2000 | 124 | 0.040 |
Why?
| Physical Chromosome Mapping | 1 | 1999 | 17 | 0.040 |
Why?
| Gorilla gorilla | 1 | 2000 | 22 | 0.040 |
Why?
| Time Factors | 2 | 2008 | 6568 | 0.040 |
Why?
| Brain Neoplasms | 1 | 2008 | 1137 | 0.040 |
Why?
| HeLa Cells | 2 | 2000 | 602 | 0.040 |
Why?
| Tumor Cells, Cultured | 2 | 2000 | 928 | 0.040 |
Why?
| Follow-Up Studies | 1 | 2008 | 4917 | 0.040 |
Why?
| Macaca mulatta | 1 | 2000 | 153 | 0.040 |
Why?
| Enhancer Elements, Genetic | 1 | 2000 | 177 | 0.040 |
Why?
| Locomotion | 1 | 2020 | 98 | 0.040 |
Why?
| Larva | 1 | 2020 | 207 | 0.040 |
Why?
| Phylogeny | 2 | 2001 | 843 | 0.040 |
Why?
| Family Health | 1 | 1999 | 199 | 0.040 |
Why?
| Cytogenetics | 1 | 2018 | 12 | 0.040 |
Why?
| SMARCB1 Protein | 2 | 2009 | 17 | 0.040 |
Why?
| Sequence Homology, Amino Acid | 1 | 1999 | 369 | 0.040 |
Why?
| Cosmids | 1 | 1997 | 6 | 0.040 |
Why?
| Chromosomes, Artificial, Bacterial | 2 | 2010 | 18 | 0.040 |
Why?
| Carcinoma, Embryonal | 1 | 1997 | 2 | 0.040 |
Why?
| DNA Replication | 1 | 1999 | 225 | 0.030 |
Why?
| Oligodeoxyribonucleotides | 1 | 1997 | 138 | 0.030 |
Why?
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 1997 | 63 | 0.030 |
Why?
| Cytoplasm | 1 | 1997 | 260 | 0.030 |
Why?
| Random Allocation | 1 | 1997 | 351 | 0.030 |
Why?
| Cardiovascular Diseases | 1 | 2008 | 2013 | 0.030 |
Why?
| Recurrence | 2 | 2010 | 1013 | 0.030 |
Why?
| Cells, Cultured | 3 | 2011 | 4048 | 0.030 |
Why?
| Pedigree | 2 | 2010 | 491 | 0.030 |
Why?
| Cell Nucleus | 1 | 1997 | 569 | 0.030 |
Why?
| RNA | 1 | 2000 | 877 | 0.030 |
Why?
| Plasmids | 2 | 2008 | 357 | 0.030 |
Why?
| Hominidae | 1 | 1994 | 82 | 0.030 |
Why?
| Severity of Illness Index | 2 | 2013 | 2767 | 0.030 |
Why?
| Endocrine System | 1 | 2013 | 20 | 0.030 |
Why?
| Atrophy | 1 | 2013 | 165 | 0.030 |
Why?
| Aortic Stenosis, Supravalvular | 1 | 2013 | 4 | 0.030 |
Why?
| Chromosome Banding | 2 | 2005 | 21 | 0.030 |
Why?
| Fatal Outcome | 1 | 2013 | 301 | 0.030 |
Why?
| Case-Control Studies | 2 | 2011 | 3334 | 0.030 |
Why?
| Prognosis | 2 | 2011 | 3787 | 0.030 |
Why?
| Aorta, Thoracic | 1 | 2015 | 260 | 0.030 |
Why?
| Diagnosis, Differential | 1 | 2017 | 1435 | 0.020 |
Why?
| Penetrance | 1 | 2011 | 27 | 0.020 |
Why?
| Homologous Recombination | 1 | 2011 | 23 | 0.020 |
Why?
| Mitochondrial Proteins | 1 | 2013 | 234 | 0.020 |
Why?
| Gene Order | 1 | 2011 | 26 | 0.020 |
Why?
| T-Cell Acute Lymphocytic Leukemia Protein 1 | 1 | 2011 | 1 | 0.020 |
Why?
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2011 | 8 | 0.020 |
Why?
| Sclerosis | 1 | 2011 | 13 | 0.020 |
Why?
| Collagen Type VI | 1 | 2011 | 4 | 0.020 |
Why?
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2011 | 16 | 0.020 |
Why?
| Monosomy | 1 | 2010 | 11 | 0.020 |
Why?
| Genotyping Techniques | 1 | 2011 | 72 | 0.020 |
Why?
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2011 | 67 | 0.020 |
Why?
| Muscular Dystrophies | 1 | 2011 | 39 | 0.020 |
Why?
| Spermatogenesis | 1 | 2010 | 62 | 0.020 |
Why?
| Health | 1 | 2010 | 74 | 0.020 |
Why?
| Gene Rearrangement | 1 | 2010 | 151 | 0.020 |
Why?
| Spermatozoa | 1 | 2010 | 91 | 0.020 |
Why?
| Receptor, Metabotropic Glutamate 5 | 1 | 2009 | 5 | 0.020 |
Why?
| Receptor-Like Protein Tyrosine Phosphatases, Class 2 | 1 | 2009 | 10 | 0.020 |
Why?
| Jagged-1 Protein | 1 | 2009 | 24 | 0.020 |
Why?
| Serrate-Jagged Proteins | 1 | 2009 | 29 | 0.020 |
Why?
| Loss of Heterozygosity | 1 | 2009 | 44 | 0.020 |
Why?
| Receptors, Metabotropic Glutamate | 1 | 2009 | 39 | 0.020 |
Why?
| Ultrasonography | 1 | 2013 | 727 | 0.020 |
Why?
| Capillaries | 1 | 2009 | 98 | 0.020 |
Why?
| Alagille Syndrome | 1 | 2009 | 33 | 0.020 |
Why?
| Genes, Tumor Suppressor | 1 | 2009 | 86 | 0.020 |
Why?
| Concept Formation | 1 | 2008 | 29 | 0.020 |
Why?
| Quality Control | 1 | 2008 | 154 | 0.020 |
Why?
| Population Groups | 1 | 2008 | 60 | 0.020 |
Why?
| Coloboma | 1 | 2008 | 4 | 0.020 |
Why?
| Hybrid Cells | 2 | 2000 | 50 | 0.020 |
Why?
| Pulmonary Veins | 1 | 2009 | 95 | 0.020 |
Why?
| Models, Biological | 2 | 2008 | 1702 | 0.020 |
Why?
| Calcium-Binding Proteins | 1 | 2009 | 213 | 0.020 |
Why?
| Doxorubicin | 1 | 2009 | 319 | 0.020 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2009 | 376 | 0.020 |
Why?
| Proto-Oncogene Proteins | 1 | 2011 | 636 | 0.020 |
Why?
| MAP Kinase Signaling System | 1 | 2008 | 305 | 0.020 |
Why?
| DNA, Cruciform | 1 | 2005 | 4 | 0.020 |
Why?
| Blotting, Western | 1 | 2008 | 1188 | 0.020 |
Why?
| Biomarkers | 1 | 2017 | 3874 | 0.020 |
Why?
| Family | 1 | 2010 | 650 | 0.020 |
Why?
| Genomic Instability | 1 | 2005 | 47 | 0.020 |
Why?
| COS Cells | 1 | 2005 | 185 | 0.020 |
Why?
| Fetus | 1 | 2009 | 764 | 0.010 |
Why?
| Primed In Situ Labeling | 1 | 2003 | 1 | 0.010 |
Why?
| Neurofibromin 1 | 1 | 2003 | 24 | 0.010 |
Why?
| Centromere | 1 | 2003 | 47 | 0.010 |
Why?
| Membrane Proteins | 1 | 2009 | 1100 | 0.010 |
Why?
| Algorithms | 1 | 2010 | 1626 | 0.010 |
Why?
| Introns | 1 | 2003 | 242 | 0.010 |
Why?
| Exons | 1 | 2003 | 330 | 0.010 |
Why?
| Lymphocytes | 1 | 2003 | 369 | 0.010 |
Why?
| Reproducibility of Results | 1 | 2009 | 3042 | 0.010 |
Why?
| DNA, Recombinant | 1 | 2000 | 46 | 0.010 |
Why?
| Blotting, Northern | 1 | 2000 | 202 | 0.010 |
Why?
| Chromosome Fragility | 1 | 2000 | 2 | 0.010 |
Why?
| 3T3 Cells | 1 | 2000 | 151 | 0.010 |
Why?
| Telomere | 1 | 2003 | 231 | 0.010 |
Why?
| Obesity | 1 | 2013 | 2844 | 0.010 |
Why?
| Mutagenesis | 1 | 2000 | 178 | 0.010 |
Why?
| RNA Stability | 1 | 2000 | 101 | 0.010 |
Why?
| Adaptor Proteins, Vesicular Transport | 1 | 1999 | 45 | 0.010 |
Why?
| Prospective Studies | 1 | 2011 | 7060 | 0.010 |
Why?
| Sequence Tagged Sites | 1 | 1997 | 4 | 0.010 |
Why?
| Chromosomes, Artificial, Yeast | 1 | 1997 | 4 | 0.010 |
Why?
| Chromosomes, Bacterial | 1 | 1997 | 8 | 0.010 |
Why?
| Tomography, X-Ray Computed | 1 | 2007 | 2530 | 0.010 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 1999 | 420 | 0.010 |
Why?
| Bacteriophages | 1 | 1997 | 93 | 0.010 |
Why?
| Sequence Analysis | 1 | 1995 | 38 | 0.010 |
Why?
| Risk Factors | 1 | 2009 | 9792 | 0.010 |
Why?
| Mutagenesis, Insertional | 1 | 1995 | 66 | 0.010 |
Why?
| Rodentia | 1 | 1995 | 47 | 0.010 |
Why?
| Polymorphism, Restriction Fragment Length | 1 | 1994 | 69 | 0.010 |
Why?
| Africa | 1 | 1994 | 96 | 0.010 |
Why?
| Treatment Outcome | 1 | 2007 | 10239 | 0.010 |
Why?
| Middle Aged | 1 | 2013 | 30977 | 0.010 |
Why?
| Species Specificity | 1 | 1990 | 566 | 0.010 |
Why?
|
|
Shaikh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|